Why UK Patients Choose EverydayMeds for Weight Loss
Prescription Weight Loss: Understanding Mounjaro vs Wegovy Cost Differences
When evaluating Mounjaro vs Wegovy cost for prescription weight loss, the fundamental difference lies in their mechanisms and dosing structures. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones, whilst Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist. Both are prescription-only medicines requiring clinical assessment and ongoing medical supervision alongside a reduced-calorie diet and increased physical activity.
The cost comparison becomes more complex when considering that Wegovy follows a structured five-dose escalation over 16 weeks, starting at 0.25mg and reaching maintenance dose of 2.4mg. Mounjaro uses a different escalation pattern with its own pricing structure. At EverydayMeds, we provide transparent pricing for both treatments, allowing patients to make informed decisions based on their clinical needs and budget considerations rather than marketing claims.
Wegovy Pricing Structure: Complete UK Cost Breakdown
Understanding the true Mounjaro vs Wegovy cost requires examining the complete dose escalation journey. Wegovy pricing at EverydayMeds starts with 0.25mg at £79.99 for the initial four-week period, progressing through 0.5mg (£94.99), 1mg (£99.99), and 1.7mg (£139.99) before reaching the maintenance dose of 2.4mg at £209.99. New customers benefit from our FIRST40 discount code applied at checkout, whilst returning patients use DOSE25 for ongoing savings.
Our bundle options provide convenience for treatment continuity, such as the Intro Trio (0.25mg, 0.5mg, and 1mg) for £299.99, covering the first three months of treatment. The Ultimate Stability Trio offers three 2.4mg pens for £649.99, ensuring three months of maintenance supply. These bundles eliminate the need for multiple orders whilst guaranteeing treatment availability through our temperature-controlled supply chain managed by our GPhC-registered pharmacy (#9012878).
Clinical Evidence: Wegovy vs Mounjaro Cost-Effectiveness
When comparing Mounjaro vs Wegovy cost-effectiveness, both treatments have demonstrated significant weight management benefits in their respective clinical trials. Wegovy's STEP trials, including the landmark study by Wilding et al. published in NEJM 2021, showed patients achieving approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions. The recent SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events among patients taking Wegovy.
However, direct comparison of trial results between Mounjaro and Wegovy requires caution due to different study populations, endpoints, and methodologies. Both treatments work through appetite regulation and enhanced satiety, but individual responses vary significantly. Cost-effectiveness ultimately depends on personal response, tolerance, and the ability to maintain treatment long-term, making clinical assessment crucial for determining the most suitable option.
How Wegovy Works: The Science Behind Prescription Weight Loss
Wegovy's mechanism as a GLP-1 receptor agonist provides the foundation for understanding its role in prescription weight loss and the justification for its cost. The active ingredient semaglutide mimics the natural incretin hormone GLP-1, which is normally released by the intestines after eating to signal fullness to the brain. By activating GLP-1 receptors, Wegovy may help reduce appetite, slow gastric emptying, and promote earlier satiety after meals. This physiological approach to weight management works through the body's existing appetite regulation systems rather than stimulant-based mechanisms. The once-weekly injection format provides consistent hormone levels, potentially offering better compliance compared to daily medications whilst working alongside dietary and exercise interventions.
Streamlined Ordering Process: From Assessment to Delivery
EverydayMeds has designed our ordering process to make the Mounjaro vs Wegovy cost comparison practical and accessible. Our 3-minute online clinical assessment captures essential medical history, current medications, and treatment goals, ensuring appropriate prescribing decisions. Qualified prescribers review each assessment within our standard 3 working days, with express 24-hour review available for urgent needs. Once approved, our temperature-controlled next-day delivery ensures medication integrity from our climate-controlled storage facilities. Our pharmacy team coordinates directly with prescribers for any clinical queries, dose adjustments, or side effect management, providing comprehensive support throughout your treatment journey.
Storage and Practical Considerations: Mounjaro vs Wegovy Cost Analysis
Storage requirements significantly impact the practical Mounjaro vs Wegovy cost comparison beyond the medication price. Wegovy offers superior storage flexibility, remaining stable for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This advantage proves valuable for travel, reducing the risk of medication spoilage and associated replacement costs. The FlexTouch pen delivery system provides precise dosing with clear dose escalation markings, reducing waste from incorrect dosing. Each pen contains four doses, with patients self-administering once weekly, typically on the same day each week for optimal hormone level consistency.
Long-term Investment: Understanding Prescription Weight Loss Value
The true Mounjaro vs Wegovy cost evaluation extends beyond initial pricing to consider long-term health investment value. Weight management represents a chronic condition requiring ongoing treatment, with clinical evidence suggesting weight regain occurs when medication is discontinued. The STEP 1 extension study showed patients regaining approximately two-thirds of lost weight within one year of stopping Wegovy, emphasising the importance of sustained treatment commitment.
This long-term perspective makes factors like storage stability, injection tolerance, and individual efficacy crucial for cost-effectiveness. Some patients may achieve their goals more readily with one treatment over another, potentially reducing the overall duration and cost of intervention. Our clinical team helps patients understand these long-term considerations during the assessment process, ensuring realistic expectations about treatment duration and associated costs.
Making Your Choice: Expert Guidance for Prescription Weight Loss
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns with your clinical profile and cost considerations. Our streamlined assessment process, transparent pricing with discount codes FIRST40 for new customers and DOSE25 for returning patients, combined with next-day delivery and ongoing clinical support, ensures you receive appropriate treatment without unnecessary delays or hidden costs. Start your 3-minute assessment today at https://everydaymeds.co.uk/collections/wegovy to begin your prescription weight loss journey with confidence and clinical expertise.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
